December 18, 2015 / 5:38 PM / 3 years ago

BUZZ-U.S. STOCKS ON THE MOVE-Biomarin, Walt Disney, Darden, Tronox

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter,; for the Morning News Call newsletter, U.S. stock indexes were lower on Friday as crude oil prices headed for their third straight weekly loss on global oversupply concerns. The Dow Jones industrial average was down 1.67 percent at 17,203.68, the S&P 500 was down 1.37 percent at 2,013.9 and the Nasdaq Composite was down 1.19 percent at 4,942.956.


The U.S. Food and Drug Administration has postponed by three months its decision on Intercept Pharmaceuticals’ marketing application for its lead drug, to treat a kind of liver disease.

** CARMAX INC, $51.8, -9.36 pct

The largest U.S. used-car seller reports Q3 revenue and profit below average analyst estimates as store traffic decreased

** KNIGHT TRANSPORTATION INC, $22.97, -6.28 pct

The company cuts Q4 EPS view to 31-33 cents from 36-38 cents. Knight says lower revenue per total mile hurt trucking and logistics business, reducing EPS by 3-4 cents.

** DARDEN RESTAURANTS INC, $62.44, +6.94 pct

The olive Garden restaurant chain owner raises full-year profit and same-restaurant sales forecast, citing strong performance in Q2

** RED HAT INC, $80.85, +2.52 pct

The Linux OS distributor raised its full-year revenue forecast for the second time, helped by a 14 percent jump in deferred revenue. The company reported better-than-expected Q3 profit, boosted by higher software subscription revenue.

** CENTENE CORP, $64.74, +4.66 pct

The drugmaker raised its 2015 profit forecast and reaffirmed its guidance for revenue, ahead of completing its $6.3 billion acquisition of smaller health insurer Health Net Inc.

** WALT DISNEY CO, $107.9, -3.67 pct

BTIG becomes first brokerage among 33 to recommend selling stock. Brokerage says Disney’s “cable network profitability will meaningfully underperform investor expectations” as it overpaid for sports rights based on “overly aggressive” forecasts for video subscriber growth.

** BIOMARIN PHARMACEUTICAL INC, $103.87, +3.21 pct

The U.S. Food and Drug Administration pushed back its deadline to decide on drug developer’s lead drug, not rejecting it outright, making shareholders optimistic.

** GOLAR LNG PARTNERS LP, $10.54, +21.71 pct

The LNG supplier to buy back $25 mln outstanding common units.

** BLACKBERRY LTD, $8.605, +10.32 pct

The phone maker reported a fiscal third-quarter loss as widely anticipated, but posted its first quarter-to-quarter revenue gain in over two years, indicating that turnaround efforts may be gaining traction.

** MBI INC, $6.05, +11.83 pct

** AMBAC FINANCIAL, $14.5, +4.62 pct

** ASSURED GUARANTY, $26.3, +3.91 pct

All bond insurers rally higher after Bloomberg report Puerto Rico Electric Power Authority reached a tentative deal with bond insurers to restructure debt.

** TRONOX LTD, $3.38, +12.67 pct

The titanium-dioxide maker says to hike titanium dioxide prices by $150 per metric ton from Jan. 1, or as contracts allow.

** YIRENDAI LTD, $8.68

The consumer finance arm of Chinese peer-to-peer (P2P) lender CreditEase made a tepid U.S. market debut on Friday, with its shares trading lower than the offer price of $10.

** MICROSOFT INC, $54.8001, -1.62 pct

Goldman Sachs removes its long-held “sell” call on Microsoft shares, admitting it underestimated investors’ enthusiasm for company’s progress on cloud computing.

** SMITH & NEPHEW, $34.81, +4.03 pct

The company's shares jump on report that Stryker has made a bid for the pharma company. Two traders cite a report on on a possible deal. (

** FOSSIL GROUP INC, $36.36, -3.81 pct

Analysts at Goldman Sachs cuts rating to “sell” from “neutral”. Expect company’s organic sales to decline mid-single digits on average over next two years; foreign exchange to be added pressure on business - Goldman analysts write in note.

** QIHOO 360 TECHNOLOGY CO, $72.97, +1.62 pct

The Chinese mobile security software maker said it agreed to be acquired by a consortium of investors for about $9.3 billion, including about $1.6 billion of debt. (Compiled by Rosmi Shaji in Bengaluru; Edited by Don Sebastian)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below